These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 39166605

  • 1. Synergy between isobavachalcone and doxorubicin suppressed the progression of anaplastic thyroid cancer through ferroptosis activation.
    Lin S, Cai H, Song X.
    Braz J Med Biol Res; 2024; 57():e13679. PubMed ID: 39166605
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Role of Krüppel-Like Factor 4 in the Maintenance of Chemoresistance of Anaplastic Thyroid Cancer.
    Lee SI, Kim DK, Seo EJ, Choi EJ, Kwon YW, Jang IH, Lee JC, Kim HY, Shong M, Kim JH, Kim SJ.
    Thyroid; 2017 Nov; 27(11):1424-1432. PubMed ID: 28920531
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. miR-381-3p attenuates doxorubicin resistance in human anaplastic thyroid carcinoma via targeting homeobox A9.
    Zhang Y, Li K, Wang W, Han J.
    Int J Exp Pathol; 2021 Aug; 102(4-5):209-217. PubMed ID: 34719830
    [Abstract] [Full Text] [Related]

  • 7. Isobavachalcone induces hepatotoxicity in zebrafish embryos and HepG2 cells via the System Xc--GSH-GPX4 signaling pathway in ferroptosis response.
    Ni X, Gao C, Zhu X, Zhang X, Fang Y, Hao Z.
    J Appl Toxicol; 2024 Aug; 44(8):1139-1152. PubMed ID: 38581191
    [Abstract] [Full Text] [Related]

  • 8. Doxorubicin has a synergistic cytotoxicity with cucurbitacin B in anaplastic thyroid carcinoma cells.
    Kim SH, Kang JG, Kim CS, Ihm SH, Choi MG, Yoo HJ, Lee SJ.
    Tumour Biol; 2017 Feb; 39(2):1010428317692252. PubMed ID: 28218042
    [Abstract] [Full Text] [Related]

  • 9. Photodynamic therapy inhibits cancer progression and induces ferroptosis and apoptosis by targeting P53/GPX4/SLC7A11 signaling pathways in cholangiocarcinoma.
    Yan X, Li Z, Chen H, Yang F, Tian Q, Zhang Y.
    Photodiagnosis Photodyn Ther; 2024 Jun; 47():104104. PubMed ID: 38679154
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Potentiated anti-tumor effects of BETi by MEKi in anaplastic thyroid cancer.
    Zhu X, Park S, Lee WK, Cheng SY.
    Endocr Relat Cancer; 2019 Sep; 26(9):739-750. PubMed ID: 31272080
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. MITOL/MARCH5 determines the susceptibility of cardiomyocytes to doxorubicin-induced ferroptosis by regulating GSH homeostasis.
    Kitakata H, Endo J, Matsushima H, Yamamoto S, Ikura H, Hirai A, Koh S, Ichihara G, Hiraide T, Moriyama H, Shirakawa K, Goto S, Katsumata Y, Anzai A, Kataoka M, Tokuyama T, Ishido S, Yanagi S, Fukuda K, Sano M.
    J Mol Cell Cardiol; 2021 Dec; 161():116-129. PubMed ID: 34390730
    [Abstract] [Full Text] [Related]

  • 16. Resibufogenin inhibited colorectal cancer cell growth and tumorigenesis through triggering ferroptosis and ROS production mediated by GPX4 inactivation.
    Shen LD, Qi WH, Bai JJ, Zuo CY, Bai DL, Gao WD, Zong XL, Hao TT, Ma Y, Cao GC.
    Anat Rec (Hoboken); 2021 Feb; 304(2):313-322. PubMed ID: 31961485
    [Abstract] [Full Text] [Related]

  • 17. Effect of mesoporous silica nanoparticles co‑loading with 17‑AAG and Torin2 on anaplastic thyroid carcinoma by targeting VEGFR2.
    Wang C, Zhang R, Tan J, Meng Z, Zhang Y, Li N, Wang H, Chang J, Wang R.
    Oncol Rep; 2020 May; 43(5):1491-1502. PubMed ID: 32323855
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Ketamine Induces Ferroptosis of Liver Cancer Cells by Targeting lncRNA PVT1/miR-214-3p/GPX4.
    He GN, Bao NR, Wang S, Xi M, Zhang TH, Chen FS.
    Drug Des Devel Ther; 2021 May; 15():3965-3978. PubMed ID: 34566408
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological effects of vinorelbine in combination with lenvatinib in anaplastic thyroid cancer.
    Di Desidero T, Orlandi P, Gentile D, Banchi M, Alì G, Kusmic C, Armanetti P, Cayme GJ, Menichetti L, Fontanini G, Francia G, Bocci G.
    Pharmacol Res; 2020 Aug; 158():104920. PubMed ID: 32461187
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.